2022 – A Year in Review

2022 – A Year in Review As 2022 draws to a close, Khondrion’s CEO Jan Smeitink reflects on the significant progress achieved by Khondrion in its development of new treatment options for patients suffering from inherited mitochondrial diseases and looks ahead at what...

Interview with Tom Pulles, Chief Medical Officer at Khondrion

Tell us about your career before joining KhondrionI started my career as a physician in the Dutch Navy, 22 years ago, following the completion of my medical degree at Utrecht University. From there I spent the next two decades working in global and medical affairs...